Industry

hc1 and Simple HealthKit combine AI-powered care gap intelligence with end-to-end patient engagement, screening, and results routing to drive measurable clinical and financial outcomes. INDIANAPOLIS–(BUSINESS WIRE)–hc1®, the leader in AI-powered lab diagnostic intelligence, and Simple HealthKit, an intelligent end-to-end patient engagement and gap closure platform, today announced a strategic partnership to help health systems, health … [Read more…]

Evening honors founder Danny Thomas’ legacy and the Middle Eastern community’s support for St. Jude NEW YORK–(BUSINESS WIRE)–The St. Jude Hope & Heritage Gala soared to new heights by raising $1.4 million for St. Jude Children’s Research Hospital® on April 25 at Cipriani Wall Street, bringing together more than 650 community and philanthropic leaders and … [Read more…]

DUBAI, United Arab Emirates–(BUSINESS WIRE)–On the occasion of International Nurses Day, Aster DM Healthcare has announced the Top 10 finalists for the fifth edition of the Aster Guardians Global Nursing Award 2026, selected from over 134,000 registrations across 214* countries and economies. One of the Top 10 finalists will be honoured with the grand title … [Read more…]

Investment will scale PeterMD’s Medicine 3.0 platform in a fast-growing $200 billion market as consumers prioritize affordable, personalized and preventative healthcare VERO BEACH, Fla.–(BUSINESS WIRE)–PeterMD, a direct-to-consumer health optimization platform trusted by more than 400,000 patients, today announced a majority equity investment from Lorient, a private investment firm focused exclusively on healthcare service and technology … [Read more…]

− Reductions in All-Cause Mortality and Recurrent Cardiovascular Events Maintained Across Key Patient Subgroups, Including Patients Taking a Broad Range of Heart Failure Therapies – − Pooled Analysis of Over 25,000 Patient-Years of Experience with TTR-Silencing RNAi Therapies Shows a Consistent Safety Profile, Including No Clinically Meaningful Ocular Effects of Vitamin A Lowering – − … [Read more…]

VIENNA, Va.–(BUSINESS WIRE)–$CVM #Multikine–CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts public offering of 6,000,000 shares of its common stock at an offering price of $1.20 per share. Total gross proceeds from the offering, before deducting the placement agent’s fees and … [Read more…]

Firefly’s clinically-integrated health plan continues to drive financial results for self-insured employers while delivering health outcomes and member satisfaction WATERTOWN, Mass.–(BUSINESS WIRE)–Firefly Health, a clinically-integrated health plan, announced a 15% lower total cost of care (TCOC) in 2025 across its Administrative Services Only (ASO) book of business when compared against a market-typical benchmark. All customers … [Read more…]

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Charlie Wagner, Chief Operating and Financial Officer, will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026, at 2:35 p.m. ET. Dr. Reshma Kewalramani, Chief Executive Officer and President, will … [Read more…]

ISG report shows enterprise AI becoming a core operational layer, delivering measurable impact at scale STAMFORD, Conn.–(BUSINESS WIRE)–$III #AI–Healthcare organizations are embedding advanced AI capabilities into core operations to increase efficiency, reduce administrative burdens and enhance care delivery, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global … [Read more…]

Presentations of results from the positive TETON phase 3 pivotal studies of inhaled treprostinil in idiopathic pulmonary fibrosis (IPF) include efficacy and safety results from TETON-1 and integrated results from TETON-1 and TETON-2 Results from the successful ADVANCE OUTCOMES study of ralinepag in pulmonary arterial hypertension (PAH) will be presented Additional presentations include an interim … [Read more…]